Artesunate Inhibits Renal Ischemia Reperfusion-Stimulated Lung Inflammation in Rats by Activating HO-1 Pathway
- 202 Downloads
- 2 Citations
ABSTRACT
Artesunate (AS), a semi-synthetic derivative of Artemisia, has been shown to exert a wide range of pharmacological effects, such as anti-inflammatory and antioxidant functions. However, the protective functions of AS on renal ischemia reperfusion injury (RIR)-stimulated lung inflammation remain unclear. In this research, acute lung injury (ALI) was stimulated by renal ischemia reperfusion injury (RIR). AS (15 mg/kg) was intraperitoneal administrated to rat 1 h before RIR stimulation. Serum and pulmonary NO, MDA, IL-6, MIP-2, and PGE2 levels, arterial blood gas and biochemistry, lung wet/dry weight ratio and MPO activity, total cell number and protein concentration in BALF, tissue histology, and NF-κB expression were determined. The results indicated that serum and pulmonary NO, MDA, IL-6, MIP-2, and PGE2 levels, lung wet/dry weight ratio and MPO activity, total cell number, and protein concentration in BALF enhanced after RIR stimulation. These alterations were mitigated by AS. AS attenuated lung wet/dry weight ratio and MPO activity, total cell number, and protein concentration in BALF. AS attenuated RIR-stimulated pulmonary NF-κB phosphorylation. In addition, these previously mentioned actions of AS were antagonized by suppressing HO-1 pathway. However, RIR-stimulated arterial blood gas and biochemistry and lung histopathology were also attenuated by AS. In summary, AS inhibited RIR-stimulated lung inflammation by activating HO-1 pathway.
KEY WORDS
artesunate renal ischemia reperfusion injury acute lung injury HO-1 NF-κBNotes
Authors’ Contributions
Zhaohui Liu: conception, design, analysis and interpretation of data; writing the manuscript. Junjie Zhang: conception, design, analysis and interpretation of data; writing the manuscript. Shitong Li: analysis and interpretation of data; writing the manuscript. Jihong Jiang: conception, design, analysis and interpretation of data; writing the manuscript.
Compliance with Ethical Standards
All procedures were performed in accordance with the Declaration of Helsinki of the World Medical Association. The study was approved by the ethics committee of Shanghai First People’s Hospital, Shanghai, China.
Conflicts of Interest
The authors declare that they have no conflict of interest.
References
- 1.Li, W.F., K. Yang, P. Zhu, H.Q. Zhao, Y.H. Song, K.C. Liu, and W.F. Huang. 2017. Genistein ameliorates ischemia/reperfusion-induced renal injury in a SIRT1-dependent manner. Nutrients 9 (4): 403.CrossRefPubMedCentralGoogle Scholar
- 2.Seifi, B., M. Kadkhodaee, A. Najafi, and A. Mahmoudi. 2014. Protection of liver as a remote organ after renal ischemia-reperfusion injury by renal ischemic postconditioning. Int J Nephrol 2014: 120391.CrossRefPubMedPubMedCentralGoogle Scholar
- 3.Youssef, M.I., A.A. Mahmoud, and R.H. Abdelghany. 2015. A new combination of sitagliptin and furosemide protects against remote myocardial injury induced by renal ischemia/reperfusion in rats. Biochemical Pharmacology 96: 20–29.CrossRefPubMedGoogle Scholar
- 4.Gu, J., J. Chen, P. Xia, G. Tao, H. Zhao, and D. Ma. 2011. Dexmedetomidine attenuates remote lung injury induced by renal ischemia-reperfusion in mice. Acta Anaesthesiologica Scandinavica 55: 1272–1278.CrossRefPubMedGoogle Scholar
- 5.Meng, Q.T., C. Cao, Y. Wu, H.M. Liu, W. Li, Q. Sun, R. Chen, Y.G. Xiao, L.H. Tang, Y. Jiang, Y. Leng, S.Q. Lei, C.C. Lee, D.M. Barry, X. Chen, and Z.Y. Xia. 2016. Ischemic post-conditioning attenuates acute lung injury induced by intestinal ischemia-reperfusion in mice: Role of Nrf2. Laboratory Investigation 96: 1087–1104.CrossRefPubMedGoogle Scholar
- 6.Ota, S., T. Yazawa, K. Tojo, Y. Baba, M. Uchiyama, T. Goto, and K. Kurahashi. 2016. Adrenaline aggravates lung injury caused by liver ischemia-reperfusion and high-tidal-volume ventilation in rats. J Intensive Care 4: 8.CrossRefPubMedPubMedCentralGoogle Scholar
- 7.Wu, S.Y., S.E. Tang, F.C. Ko, G.C. Wu, K.L. Huang, and S.J. Chu. 2015. Valproic acid attenuates acute lung injury induced by ischemia-reperfusion in rats. Anesthesiology 122: 1327–1337.CrossRefPubMedGoogle Scholar
- 8.Mitaka, C., M.K. Si, M. Tulafu, Q. Yu, T. Uchida, S. Abe, M. Kitagawa, S. Ikeda, Y. Eishi, and M. Tomita. 2014. Effects of atrial natriuretic peptide on inter-organ crosstalk among the kidney, lung, and heart in a rat model of renal ischemia-reperfusion injury. Intensive Care Med Exp 2: 28.CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Domenech, P., T. Perez, A. Saldarini, P. Uad, and C.G. Musso. 2017. Kidney-lung pathophysiological crosstalk: its characteristics and importance. International Urology and Nephrology 11: 1–5.Google Scholar
- 10.Tulafu, M., C. Mitaka, M.K. Hnin Si, S. Abe, M. Kitagawa, S. Ikeda, Y. Eishi, S. Kurata, and M. Tomita. 2014. Atrial natriuretic peptide attenuates kidney-lung crosstalk in kidney injury. The Journal of Surgical Research 186: 217–225.CrossRefPubMedGoogle Scholar
- 11.Kao, M.C., C.H. Yang, W.C. Chou, J.R. Sheu, and C.J. Huang. 2015. Cepharanthine mitigates lung injury in lower limb ischemia-reperfusion. The Journal of Surgical Research 199: 647–656.CrossRefPubMedGoogle Scholar
- 12.Gao, W., Y. Guo, and H. Yang. 2017. Platycodin D protects against cigarette smoke-induced lung inflammation in mice. International Immunopharmacology 47: 53–58.CrossRefPubMedGoogle Scholar
- 13.Hsieh, Y.H., J.S. Deng, H.P. Pan, J.C. Liao, S.S. Huang, and G.J. Huang. 2017. Sclareol ameliorate lipopolysaccharide-induced acute lung injury through inhibition of MAPK and induction of HO-1 signaling. International Immunopharmacology 44: 16–25.CrossRefPubMedGoogle Scholar
- 14.Li, J., D. Tong, J. Liu, F. Chen, and Y. Shen. 2016. Oroxylin A attenuates cigarette smoke-induced lung inflammation by activating Nrf2. International Immunopharmacology 40: 524–529.CrossRefPubMedGoogle Scholar
- 15.Shen, B., C. Zhao, C. Chen, Z. Li, Y. Li, Y. Tian, and H. Feng. 2017. Picroside II protects rat lung and A549 cell against LPS-induced inflammation by the NF-kappaB pathway. Inflammation 1: 1–0.Google Scholar
- 16.Yao, H., Y. Sun, S. Song, Y. Qi, X. Tao, L. Xu, L. Yin, X. Han, Y. Xu, H. Li, H. Sun, and J. Peng. 2017. Protective effects of Dioscin against lipopolysaccharide-induced acute lung injury through inhibition of oxidative stress and inflammation. Frontiers in Pharmacology 8: 120.PubMedPubMedCentralGoogle Scholar
- 17.Paine, A., B. Eiz-Vesper, R. Blasczyk, and S. Immenschuh. 2010. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochemical Pharmacology 80: 1895–1903.CrossRefPubMedGoogle Scholar
- 18.Mitterstiller, A.M., D. Haschka, S. Dichtl, M. Nairz, E. Demetz, H. Talasz, M.P. Soares, E. Einwallner, H. Esterbauer, F.C. Fang, S. Geley, and G. Weiss. 2016. Heme oxygenase 1 controls early innate immune response of macrophages to Salmonella Typhimurium infection. Cellular Microbiology 18: 1374–1389.CrossRefPubMedGoogle Scholar
- 19.Matsuda, A., W.L. Yang, A. Jacob, M. Aziz, S. Matsuo, T. Matsutani, E. Uchida, and P. Wang. 2014. FK866, a visfatin inhibitor, protects against acute lung injury after intestinal ischemia-reperfusion in mice via NF-kappaB pathway. Annals of Surgery 259: 1007–1017.CrossRefPubMedGoogle Scholar
- 20.Mao, Y.F., X.F. Zheng, J.M. Cai, X.M. You, X.M. Deng, J.H. Zhang, L. Jiang, and X.J. Sun. 2009. Hydrogen-rich saline reduces lung injury induced by intestinal ischemia/reperfusion in rats. Biochemical and Biophysical Research Communications 381: 602–605.CrossRefPubMedGoogle Scholar
- 21.Cao, T.H., S.G. Jin, D.S. Fei, K. Kang, L. Jiang, Z.Y. Lian, S.H. Pan, M.R. Zhao, and M.Y. Zhao. 2016. Artesunate protects against sepsis-induced lung injury via Heme Oxygenase-1 modulation. Inflammation 39: 651–662.CrossRefPubMedGoogle Scholar
- 22.Cen, Y., C. Liu, X. Li, Z. Yan, M. Kuang, Y. Su, X. Pan, R. Qin, X. Liu, J. Zheng, and H. Zhou. 2016. Artesunate ameliorates severe acute pancreatitis (SAP) in rats by inhibiting expression of pro-inflammatory cytokines and Toll-like receptor 4. International Immunopharmacology 38: 252–260.CrossRefPubMedGoogle Scholar
- 23.Lai, L., Y. Chen, X. Tian, X. Li, X. Zhang, J. Lei, Y. Bi, B. Fang, and X. Song. 2015. Artesunate alleviates hepatic fibrosis induced by multiple pathogenic factors and inflammation through the inhibition of LPS/TLR4/NF-kappaB signaling pathway in rats. European Journal of Pharmacology 765: 234–241.CrossRefPubMedGoogle Scholar
- 24.Wang, D., J. Shi, S. Lv, W. Xu, J. Li, W. Ge, C. Xiao, D. Geng, and Y. Liu. 2015. Artesunate attenuates lipopolysaccharide-stimulated proinflammatory responses by suppressing TLR4, MyD88 expression, and NF-kappaB activation in microglial cells. Inflammation 38: 1925–1932.CrossRefPubMedGoogle Scholar
- 25.Zhao, D., J. Zhang, G. Xu, and Q. Wang. 2017. Artesunate protects LPS-induced acute lung injury by inhibiting TLR4 expression and inducing Nrf2 activation. Inflammation 40 (3): 798–805.CrossRefPubMedGoogle Scholar
- 26.Jiang, L., Y. Zhang, Y. Sun, L. Hu, and D. Gao. 2015. Artesunate attenuates lung injury in paraquat-intoxicated rats via downregulation of inflammatory cytokines. Clinical Laboratory 61: 1601–1607.PubMedGoogle Scholar
- 27.Ng, D.S., W. Liao, W.S. Tan, T.K. Chan, X.Y. Loh, and W.S. Wong. 2014. Anti-malarial drug artesunate protects against cigarette smoke-induced lung injury in mice. Phytomedicine 21: 1638–1644.CrossRefPubMedGoogle Scholar
- 28.Zhao, D., J. Zhang, G. Xu, and Q. Wang. 2017. Artesunate protects LPS-induced acute lung injury by inhibiting TLR4 expression and inducing Nrf2 activation. Inflammation 40: 798–805.CrossRefPubMedGoogle Scholar
- 29.Oztay, F., B. Kara-Kisla, N. Orhan, R. Yanardag, and S. Bolkent. 2016. The protective effects of prostaglandin E1 on lung injury following renal ischemia-reperfusion in rats. Toxicology and Industrial Health 32: 1684–1692.CrossRefPubMedGoogle Scholar
- 30.Leung, W.S., M.L. Yang, S.S. Lee, C.W. Kuo, Y.C. Ho, R. Huang-Liu, H.W. Lin, and Y.H. Kuan. 2017. Protective effect of zerumbone reduces lipopolysaccharide-induced acute lung injury via antioxidative enzymes and Nrf2/HO-1 pathway. International Immunopharmacology 46: 194–200.CrossRefPubMedGoogle Scholar
- 31.Shen, X., B. Hu, G. Xu, F. Chen, R. Ma, N. Zhang, J. Liu, X. Ma, J. Zhu, Y. Wu, and R. Shen. 2017. Activation of Nrf2/HO-1 pathway by glycogen synthase kinase-3beta inhibition attenuates renal ischemia/reperfusion injury in diabetic rats. Kidney & Blood Pressure Research 42: 369–378.CrossRefGoogle Scholar
- 32.Wu, K.C., S.S. Huang, Y.H. Kuo, Y.L. Ho, C.S. Yang, Y.S. Chang, and G.J. Huang. 2017. Ugonin M, a Helminthostachys zeylanica constituent, prevents LPS-induced acute lung injury through TLR4-mediated MAPK and NF-kappaB signaling pathways. Molecules 22 (4): 573.CrossRefGoogle Scholar
- 33.Y. Xu, and L. Liu. 2017. Curcumin alleviates macrophage activation and lung inflammation induced by influenza virus infection through inhibiting the NF-kappaB signaling pathway. Influenza and Other Respiratory Viruses 11(5): 457–463.Google Scholar
- 34.Lin, Q., X. Qin, M. Shi, Z. Qin, Y. Meng, and S. Guo. 2017. Schisandrin B inhibits LPS-induced inflammatory response in human umbilical vein endothelial cells by activating Nrf2. International Immunopharmacology 49: 142–147.CrossRefPubMedGoogle Scholar
- 35.Liu, Y., M. Song, G. Zhu, X. Xi, K. Li, C. Wu, and L. Huang. 2017. Corynoline attenuates LPS-induced acute lung injury in mice by activating Nrf2. International Immunopharmacology 48: 96–101.CrossRefPubMedGoogle Scholar